Lead Product(s) : Frovatriptan
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Alberta Health services
Deal Size : Inapplicable
Deal Type : Inapplicable
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Details : Frovatriptan is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Headache Disorders, Secondary.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 07, 2010
Lead Product(s) : Frovatriptan
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Alberta Health services
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
